Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

NCT05914753 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Chemotherapy Effect

Interventions

DRUG: Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
DRUG: Epirubicin, Cyclophosphamide, Docetaxel

Sponsor

Zhejiang Provincial People's Hospital